Results 151 to 160 of about 1,963 (217)

Drug-Associated Alcohol Intolerance: A Real-World Disproportionality Analysis Study. [PDF]

Hosp Pharm
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

SNRK facilitates cardiac repair associated with nonischemic fibrosis: regulating transforming growth factor-beta1 levels in atrial cardiomyocytes. [PDF]

Regen Med Rep
Thirugnanam K, Rizvi F, Jahangir A, Homar P, Shabnam F, Palecek SP, Kumar SN, Pan A, Bai X, Sekine H, Ramchandran R.   +10 more
europepmc   +1 more source

Polyclonal immunoglobulin G deposits with distinctive appearance in the tubular basement membrane: a report of two cases. [PDF]

BMC Nephrol
Sakamaki Y, Hashiguchi A, Konishi K, Araki T, Tokuyama H.   +4 more
europepmc   +1 more source

Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. [PDF]

, 2002
Brändli, O., Frey, J.G., Grebski, E., Gugger, M., Karrer, W., Kuhn, M., Leuenberger, P., Paky, A., Pons, M., Rochat, T., Russi, E.W., Schibli, R., Solèr, M., Wacker, J.   +13 more
core  

Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens. [PDF]

Viruses
Saha T, Masum ZU, Biswas A, Mou MA, Ahmed S, Saha T.   +5 more
europepmc   +1 more source

Intensive bronchial dilation test: A modified method for evaluating airway reversibility. [PDF]

Asia Pac Allergy
Yang Y, Tang N, Sun Y, Liu L, Wang J, Yu P, Cao J, Zhang Y, Song X.   +8 more
europepmc   +1 more source

Evolving treatment for prematurity-associated lung disease. [PDF]

Transl Pediatr
Course CW, Kotecha SJ, Kotecha S.
europepmc   +1 more source

Engineering particle agglomeration in dry powder inhaler formulations to co- deliver drugs to the lungs [PDF]

, 2014
Jaffari, Sara
core  

Preschool children's asthma medication: parental knowledge, attitudes, practices, and adherence. [PDF]

Front Pharmacol
Tang J, Zhao Z, Guo R, Niu C, Zhang R, Wang L, Luo N.   +6 more
europepmc   +1 more source

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis. [PDF]

BDJ Open
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source